Metabolomics

Dataset Information

0

Lyso-lipid induced oligodendrocytes maturation underlie restoration of optic nerve function


ABSTRACT: Protein hyper-deimination and deficiency of lyso-phospholipids (LPC 18:1) has been associated with the pathology of demyelinating disease in both humans and mice. We uncovered interesting biology of LPC 18:1, in which LPC 18:1 induced optic nerve function restoration through oligodendrocyte maturation and remyelination in mouse model systems. Our in vitro studies show LPC 18:1 protection against neuron-ectopic hyper-deimination and stimulation of oligodendrocyte maturation, while in vivo investigations recorded optic nerve function improvement following optic nerve injections of LPC 18:1, in contrast to LPC 18:0. Thus just a change in a single bond renders a dramatic alternation in biological function. The incorporation of isobaric C13-histidine in newly synthesized myelin proteins and quantitative proteome shifts are consistent with remyelination underlying restoration in optic nerve function. These results suggest that exogenous LPC 18:1 may provide a therapeutic avenue for stemming vision loss in demyelinating diseases.

ORGANISM(S): Rat Rattus Norvegicus

TISSUE(S): Cultured Cells

DISEASE(S): Eye Disease

SUBMITTER: Sanjoy K. Bhattacharya  

PROVIDER: ST002047 | MetabolomicsWorkbench | Thu Dec 16 00:00:00 GMT 2021

REPOSITORIES: MetabolomicsWorkbench

Similar Datasets

2022-02-17 | PXD025176 | Pride
2022-02-17 | PXD024966 | Pride
2010-02-21 | E-GEOD-19298 | biostudies-arrayexpress
2022-02-17 | PXD025177 | Pride
2020-11-24 | PXD022661 | Pride
2010-10-06 | GSE21879 | GEO
2010-10-06 | E-GEOD-21879 | biostudies-arrayexpress
2010-02-01 | GSE19298 | GEO
2013-07-15 | E-GEOD-40857 | biostudies-arrayexpress
2020-05-26 | PXD016197 | Pride